Administration, Ophthalmic
"Administration, Ophthalmic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Application of pharmaceutically active agents on the tissues of the EYE.
| Descriptor ID |
D060433
|
| MeSH Number(s) |
E02.319.267.120.805
|
| Concept/Terms |
Administration, Ophthalmic- Administration, Ophthalmic
- Administrations, Ophthalmic
- Ophthalmic Administration
- Ophthalmic Administrations
- Ocular Administration
- Administration, Ocular
- Administrations, Ocular
- Ocular Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Ophthalmic".
Below are MeSH descriptors whose meaning is more specific than "Administration, Ophthalmic".
This graph shows the total number of publications written about "Administration, Ophthalmic" by people in this website by year, and whether "Administration, Ophthalmic" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Administration, Ophthalmic" by people in Profiles.
-
Comparative Efficacy of Current Topical Treatments for Dry Eye Disease: A Review of Pivotal Clinical Trials Evaluating Corneal Staining Outcomes. J Ocul Pharmacol Ther. 2025 Aug; 41(6):293-304.
-
Impact of Pupil Dilation on Optical Coherence Tomography Angiography Retinal Microvasculature in Healthy Eyes. J Glaucoma. 2020 11; 29(11):1025-1029.
-
Inhibitors of metalloprotease, ?-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication. PLoS One. 2020; 15(7):e0236175.
-
Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis. Ophthalmology. 2020 04; 127(4S):S5-S18.
-
Topical Prostaglandin Analog Use Is Associated with Increased Failure Rate of Ptosis Repair. Ophthalmology. 2020 02; 127(2):276-278.
-
Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020 01; 127(1):14-26.
-
Paediatric ocular super glue injuries: assessment of two cases. BMJ Case Rep. 2018 Sep 27; 2018.